Search results for abx831009

Fontolizumab, Abbexa, abx831009

Fontolizumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting IFNG, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Fontolizumab (marketed under the trade name HuZAF™) is a humanized monoclonal antibody which is used as an immunosuppressive drug to treat Crohn's disease.